PROMETHEUS BIOSCIENCES, INC. Realized Gains on Marketable Securities
PROMETHEUS BIOSCIENCES, INC. reported Realized Gains on Marketable Securities of $0 for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLoss · last filed 2023-05-09
- PROMETHEUS BIOSCIENCES, INC. marketable securities, realized gain (loss) for the quarter ending 2023-03-31 was $0.00.
- PROMETHEUS BIOSCIENCES, INC. marketable securities, realized gain (loss) for the quarter ending 2022-12-31 was $0.00.
- PROMETHEUS BIOSCIENCES, INC. marketable securities, realized gain (loss) for the quarter ending 2022-09-30 was $0.00.
| Period end | Marketable Securities, Realized Gain (Loss) 3 month | Marketable Securities, Realized Gain (Loss) 6 month | Marketable Securities, Realized Gain (Loss) 9 month | Marketable Securities, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2023-05-09 | $0.00 derived: sum of 3 quarters · filed 2023-05-09 | |
| 2022-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2023-05-09 | $0.00 10-Q · filed 2023-05-09 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | |||
| 2021-12-31 | $0.00 10-Q · filed 2022-11-09 |